COVID-19, Pfizer and Health Canada
Pfizer is removing its Oxbryta pill for sickle cell disease from all markets globally due to safety risks, including deaths.
Pfizer Inc. ( PFE, Financial) rose to prominence during the Covid-19 pandemic for its rapid development of a vaccine and ...
While the new mRNA vaccines from Moderna and Pfizer-BioNTech have dominated the COVID-19 vaccine story, there is another type ...
Pfizer remains an attractive capital return play with a 10X P/E ratio, despite concerns about post-COVID revenue declines.
Pfizer's and Moderna's formulas have been the go-to on pharmacy shelves, but Novavax remains an important option.
Some people are making it their mission to get Novavax, rather than Pfizer or Moderna, for their COVID booster.
Pfizer Canada says Health Canada has approved its updated COVID-19 vaccine that protects against one of the most recently ...
The mRNA vaccine, called Comirnaty, targets the KP.2 subvariant of Omicron, replacing the previous version which targeted the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback